Diversified Healthcare Trust (NASDAQ:DHC) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says

Diversified Healthcare Trust (NASDAQ:DHC) had its price objective lifted by research analysts at Royal Bank Of Canada from $5.00 to $6.00 in a note issued to investors on Monday,Benzinga reports. The brokerage presently has a “sector perform” rating on the real estate investment trust’s stock. Royal Bank Of Canada’s target price would indicate a potential downside of 17.36% from the stock’s current price.

A number of other research analysts also recently issued reports on DHC. Weiss Ratings reissued a “sell (d-)” rating on shares of Diversified Healthcare Trust in a research note on Wednesday, January 21st. B. Riley Financial reiterated a “buy” rating and issued a $6.50 target price (up from $5.50) on shares of Diversified Healthcare Trust in a report on Monday, December 15th. Finally, Zacks Research raised Diversified Healthcare Trust from a “strong sell” rating to a “hold” rating in a research note on Friday, February 20th. One analyst has rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $7.25.

Diversified Healthcare Trust Stock Up 0.3%

Shares of NASDAQ DHC opened at $7.26 on Monday. The company’s 50 day moving average price is $5.84 and its 200-day moving average price is $4.89. The company has a debt-to-equity ratio of 1.44, a quick ratio of 2.36 and a current ratio of 2.36. Diversified Healthcare Trust has a 52-week low of $2.00 and a 52-week high of $7.52. The company has a market capitalization of $1.76 billion, a P/E ratio of -6.10 and a beta of 2.39.

Diversified Healthcare Trust (NASDAQ:DHC) last announced its earnings results on Monday, February 23rd. The real estate investment trust reported ($0.09) earnings per share for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.21). The firm had revenue of $379.57 million for the quarter, compared to the consensus estimate of $392.89 million. Diversified Healthcare Trust had a negative return on equity of 15.98% and a negative net margin of 18.59%.

Insider Buying and Selling at Diversified Healthcare Trust

In other news, CEO Christopher J. Bilotto bought 20,000 shares of the business’s stock in a transaction that occurred on Monday, December 15th. The shares were bought at an average cost of $4.89 per share, for a total transaction of $97,800.00. Following the acquisition, the chief executive officer directly owned 266,285 shares in the company, valued at approximately $1,302,133.65. This trade represents a 8.12% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 10.06% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the stock. Prudential Financial Inc. grew its position in Diversified Healthcare Trust by 7.7% in the 2nd quarter. Prudential Financial Inc. now owns 2,129,197 shares of the real estate investment trust’s stock worth $7,623,000 after purchasing an additional 151,479 shares in the last quarter. Allianz Asset Management GmbH boosted its stake in shares of Diversified Healthcare Trust by 85.1% in the 3rd quarter. Allianz Asset Management GmbH now owns 206,547 shares of the real estate investment trust’s stock worth $911,000 after buying an additional 94,937 shares during the last quarter. SG Americas Securities LLC grew its holdings in shares of Diversified Healthcare Trust by 560.3% in the third quarter. SG Americas Securities LLC now owns 244,211 shares of the real estate investment trust’s stock valued at $1,077,000 after acquiring an additional 207,225 shares in the last quarter. Centersquare Investment Management LLC purchased a new stake in shares of Diversified Healthcare Trust during the third quarter valued at approximately $6,383,000. Finally, Arrowstreet Capital Limited Partnership increased its position in shares of Diversified Healthcare Trust by 22.3% during the second quarter. Arrowstreet Capital Limited Partnership now owns 1,890,628 shares of the real estate investment trust’s stock valued at $6,768,000 after acquiring an additional 345,110 shares during the last quarter. Institutional investors own 75.98% of the company’s stock.

About Diversified Healthcare Trust

Diversified Healthcare Trust is a real estate investment trust (REIT) specializing in the acquisition, ownership and management of healthcare properties across the United States. The company focuses on assets that serve the senior housing and post-acute care sectors, including skilled nursing facilities, assisted living communities, memory care centers and medical office buildings. By partnering with experienced operators, Diversified Healthcare Trust aims to generate stable, long-term cash flows through triple-net leases and percentage rent structures tailored to each property type.

The company’s portfolio spans multiple states and encompasses a mix of single-tenant and multi-tenant properties.